Diffusion tensor imaging biomarkers and clinical assessments in ALS patients: An exploratory study
Annals of Medicine and Surgery,
Journal Year:
2024,
Volume and Issue:
unknown
Published: July 22, 2024
Amyotrophic
lateral
sclerosis
(ALS)
is
a
neurodegenerative
disease
characterized
by
progressive
loss
of
upper
and
lower
motor
neurons.
Biomarkers
are
needed
to
improve
diagnosis,
gauge
progression,
evaluate
treatment.
Diffusion
tensor
imaging
(DTI)
promising
biomarker
for
detecting
microstructural
alterations
in
the
white
matter
tracts.
This
study
aimed
assess
DTI
metrics
as
biomarkers
examine
their
relationship
with
clinical
assessments
patients
ALS.
Eleven
ALS
21
healthy
controls
(HCs)
underwent
3T
MRI
DTI.
metrics,
including
fractional
anisotropy
(FA),
mean
diffusivity
(MD),
radial
(RD),
axial
(AD),
were
compared
between
key
extra-motor
tract
groups.
Group
comparisons
correlations
also
correlated
scores
disability
(ALSFRS-R),
muscle
strength
(dynamometry),
unit
(MUNIX).
Widespread
differences
found
HCs
decreased
FA
increased
metrics.
However,
MD
RD
more
sensitive
changes
Significant
interhemispheric
observed.
showed
symmetry
hemispheres
assessments.
MD,
RD,
AD
increases
significantly
ALSFRS-R
MUNIX
weaker
dynamometry
results.
reveals
damage
along
regions
patients.
can
serve
quantitative
neuroimaging
prognosis,
monitoring
Combined
analysis
imaging,
electrodiagnostic,
functional
shows
potential
characterizing
pathophysiology
progression.
Language: Английский
Quantitative Susceptibility Mapping Values Quantification in Deep Gray Matter Structures for Relapsing‐Remitting Multiple Sclerosis: A Systematic Review and Meta‐Analysis
Brain and Behavior,
Journal Year:
2024,
Volume and Issue:
14(10)
Published: Oct. 1, 2024
ABSTRACT
Background/Objectives
This
systematic
review
and
meta‐analysis
aimed
to
investigate
the
role
of
magnetic
susceptibility
(χ)
in
deep
gray
matter
(DGM)
structures,
including
putamen
(PUT),
globus
pallidus
(GP),
caudate
nucleus
(CN),
thalamus,
most
common
types
multiple
sclerosis
(MS)
relapsing‐remitting
MS
(RRMS),
using
quantitative
mapping
(QSM).
Methods
The
literature
was
systematically
reviewed
up
November
2023,
adhering
PRISMA
guidelines.
study
conducted
a
random‐effects
model
calculate
standardized
mean
difference
(SMD)
QSM
values
between
patients
with
RRMS
healthy
controls
(HCs).
Publication
bias
risk
were
also
assessed.
Results
Nine
studies
involving
1074
640
HCs
included
meta‐analysis.
results
showed
significantly
higher
PUT
(SMD
=
0.40,
95%
confidence
interval
[CI]
0.22–0.59,
p
.000),
GP
0.60,
CI
0.50–0.70,
.00),
CN
0.15–0.66,
.005)
compared
HCs.
However,
there
no
significant
differences
thalamus
−0.33,
−0.67–0.01,
.026).
Age‐
sex‐based
subgroup
analysis
demonstrated
that
younger
(<
40
years)
PUT,
GP,
groups
larger
male
populations
(>
25%)
had
more
χ.
Interestingly,
thalamic
found
decrease
over
years
age
populations.
Sex‐based
indicated
iron
levels
regardless
sex.
certain
brain
regions
(PUT,
CN)
during
early
stages
(disease
duration
<
9.6
RRMS,
but
lower
later
>
than
Discussion/Conclusion
may
serve
as
biomarker
for
understanding
χ
value
alterations
such
dysregulation
its
contribution
neurodegeneration
especially
basal
ganglia
nuclei
CN.
Language: Английский